-
-
Sales: 1300 219 875
-
Service: 1300 195 482
If you’re over 30 and have been told you’re at high risk of breast cancer — or you’ve already faced a diagnosis — you probably lie awake at night wondering whether you’re doing enough. You’re not alone. Breast cancer is the most common cancer affecting Australian women, with over 20,000 new diagnoses each year. The fear of recurrence, the anxiety about family history, and the confusion about which medication is “right” can be overwhelming.
As a doctor, I want to walk you through one of the most proven, time-tested medications we have: tamoxifen. This article isn’t just information — it’s a roadmap to help you understand whether tamoxifen could be the right choice for you, and how to access it in Australia.
Tamoxifen is a selective oestrogen receptor modulator (SERM). In simple terms, it blocks oestrogen from fuelling certain types of breast cancer cells. It has been used for more than 40 years and has saved countless lives. For premenopausal women with hormone-receptor-positive breast cancer, tamoxifen remains the gold standard. For postmenopausal women, it is a valuable option, especially when other drugs aren’t tolerated.
But tamoxifen is more than just a treatment — it can also be used to reduce the risk of developing breast cancer in high-risk women. That’s a powerful tool in your hands.
Attention: You may have heard conflicting advice about tamoxifen, anastrozole, genetic testing, and side effects. Let’s clear that up.
Interest: Tamoxifen has a proven track record in Australia, is widely available, and can be tailored to your individual situation.
Desire: Imagine having a clear plan — one that reduces your risk, fits your life stage, and is supported by your GP or specialist.
Action: By the end of this article, you’ll know exactly how to talk to your doctor and get a prescription if tamoxifen is right for you.
One of the most common questions I hear is: “Which is better — tamoxifen or anastrozole?” The answer depends on your menopausal status, side effect profile, and medical history.
| Feature | Tamoxifen | Aromatase Inhibitors (e.g. Anastrozole) |
|---|---|---|
| Best for | Premenopausal and postmenopausal women | Postmenopausal women only |
| How it works | Blocks oestrogen receptors | Lowers oestrogen production |
| Common side effects | Hot flushes, vaginal discharge, possible blood clots, endometrial changes | Joint pain, bone thinning, hot flushes |
| Bone health | Protects bone in postmenopausal women | Can weaken bones — requires monitoring |
| PBS availability in Australia | Yes, for breast cancer treatment; off-label for prevention | Yes, for postmenopausal breast cancer treatment |
So which is better? For a premenopausal woman, tamoxifen is the clear choice — anastrozole simply won’t work well while the ovaries are still producing oestrogen. For a postmenopausal woman, both can be effective. Aromatase inhibitors may slightly reduce recurrence risk further, but they come with significant bone and joint problems. Many women switch to tamoxifen because they can’t tolerate the joint pain of anastrozole. The “better” drug is the one you can take consistently with manageable side effects — and that’s a decision you and your doctor make together.
Yes. Tamoxifen is used for breast cancer risk reduction in women at high risk, including those with a strong family history or a high-risk lesion on biopsy. In Australia, this use is often off-label, meaning it is not specifically PBS-subsidised for prevention alone, but it is still a recognised and evidence-based option. Your GP or breast specialist can assess your risk using tools like the IBIS risk calculator and discuss whether tamoxifen prevention is appropriate.
For women with a confirmed genetic mutation such as BRCA2, tamoxifen may reduce the risk of hormone-receptor-positive breast cancer. For BRCA1 carriers, the benefit is less clear but may still be considered in some settings. This brings us to genetic testing.
Not routinely. You do not need genetic testing before starting tamoxifen for breast cancer treatment. The decision is based on your tumour’s hormone receptor status, not your genes. However, if you have a strong family history of breast, ovarian, or related cancers, genetic counselling and testing for BRCA1, BRCA2, and other genes is highly recommended. Knowing your genetic status can guide your overall risk management — including whether to consider risk-reducing surgery — but it is not a barrier to starting tamoxifen.
Yes, tamoxifen has a lesser-known but important role in treating desmoid tumours (aggressive fibromatosis). These non-cancerous but locally aggressive growths often have oestrogen receptors, and tamoxifen’s anti-oestrogen effect can slow or shrink them. It is usually used off-label by specialists, often in combination with NSAIDs. If you or a loved one has a desmoid tumour, tamoxifen may be a well-tolerated option worth discussing with an oncologist or sarcoma specialist.
No. Tamoxifen is not recommended while breastfeeding. It can suppress milk production and may pass into breast milk, potentially affecting the baby. Women taking tamoxifen should use effective non-hormonal contraception and avoid breastfeeding. If you are planning to breastfeed, talk to your doctor about timing — tamoxifen is usually started after breastfeeding is completed.
Yes, though it is not the most common side effect. Some women experience gastrointestinal changes, including constipation, nausea, or abdominal discomfort. The good news is that constipation is usually manageable with simple measures:
If constipation becomes bothersome, don’t stop the medication — speak with your doctor. There are many ways to manage side effects without losing the cancer-protective benefits.
| Question | Answer |
|---|---|
| Used for desmoid tumours? | Yes, off-label, especially for oestrogen-receptor-positive desmoid tumours. |
| Better than anastrozole? | Depends on menopausal status. Tamoxifen is first-line for premenopausal women. |
| Safe while breastfeeding? | No — avoid breastfeeding while taking tamoxifen. |
| Genetic testing required? | Not routine, but recommended for high-risk family history. |
| Can cause constipation? | Yes, but manageable with diet and lifestyle changes. |
| Difference from aromatase inhibitors? | Tamoxifen blocks oestrogen receptors; aromatase inhibitors lower oestrogen production. |
| Prevention in high-risk women? | Yes, used off-label in Australia for risk reduction. |
| How to get a prescription? | Through a GP or specialist after risk assessment. |
Getting tamoxifen in Australia is straightforward if you have a clear indication. Here’s the step-by-step process:
Tamoxifen is not a new, trendy drug. It’s a workhorse. It has stood the test of time because it works. For premenopausal women with hormone-receptor-positive breast cancer, tamoxifen reduces the risk of recurrence by nearly half. For high-risk women, it can cut the chance of developing breast cancer by about 30–50%. That’s a significant reduction in risk from a single daily tablet.
Yes, there are side effects. But the vast majority of women tolerate tamoxifen well, and most side effects can be managed. The alternative — living with uncontrolled risk or facing a recurrence — is far more frightening for many patients.
If you are over 30 and have a personal or family history of breast cancer, don’t wait for fear to grow. Tamoxifen may be the evidence-based solution you’ve been looking for. Speak to your Australian GP or breast specialist this week. Ask about tamoxifen, discuss your individual risk, and take the first step toward a safer future.
Your health is in your hands — and tamoxifen could be the tool that helps you protect it.
Disclaimer: This article is for educational purposes only and does not replace individual medical advice. Always consult a qualified healthcare professional before starting or changing any medication.
Sales:1300 219 875
Services:1300 195 482
How Your Fireplace Flue Works: SFS, IFS and AFS+
Gas, Wood or Electric: Which Indoor Fireplace Suits Your Living Room
Does Adding a Permanent Fireplace Increase Your Home’s Resale Value?
Exploring the Features of the New Jotul F620 and F370
Building a New Home? 6 Fireplace Decisions to Make at the Planning Stage